Overview of Melanotan 2 Receptor Pharmacology

Melanotan 2 (MT-2, cyclo[Nle4,D-Phe7]-alpha-MSH) is a cyclic heptapeptide analogue of alpha-melanocyte stimulating hormone with broad melanocortin receptor binding activity across MC1R, MC3R, MC4R, and MC5R subtypes in cell-based receptor pharmacology assays. This synthetic peptide demonstrates enhanced proteolytic stability compared to the endogenous alpha-MSH through its cyclic structure and D-amino acid substitution at position 7.

Molecular Properties

| Property | Value |

|----------|--------|

| Molecular Formula | C₅₀H₆₉N₁₅O₉ |

| Molecular Weight | 1024.18 g/mol |

| CAS Number | 121062-08-6 |

| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |

MC1R Melanogenesis Research

Receptor Expression and Binding Kinetics

MC1R is expressed on melanocyte cell lines and demonstrates high-affinity binding interactions with Melanotan 2 in radioligand displacement assays. The receptor exhibits nanomolar binding affinity (Kd ~0.2-0.5 nM) for MT-2 in membrane preparations from MC1R-transfected cell systems. Competitive binding studies using [¹²⁵I]-NDP-MSH reveal that Melanotan 2 displaces radiolabeled ligand with IC₅₀ values typically ranging from 0.1-1.0 nM in various melanocyte-derived cell models.

cAMP Signaling Pathway Activation

MC1R coupling to Gs proteins results in adenylyl cyclase activation and cyclic adenosine monophosphate (cAMP) accumulation in responsive cell systems. Melanotan 2 demonstrates potent agonist activity at MC1R with EC₅₀ values for cAMP production ranging from 0.1-0.3 nM in melanocyte cell lines. Maximum cAMP responses typically achieve 80-90% of forskolin-stimulated levels, indicating high intrinsic activity at this receptor subtype.

Tyrosinase Enzyme Activity

Downstream signaling through protein kinase A activation leads to CREB-mediated transcription of melanogenic enzymes. In vitro tyrosinase activity assays demonstrate dose-dependent increases in enzyme activity following Melanotan 2 treatment in melanocyte cultures, with maximal stimulation occurring at concentrations between 10-100 nM.

MC3R and MC4R Pharmacological Profiles

MC3R Binding and Activation

Melanotan 2 exhibits moderate binding affinity at MC3R with Kd values typically ranging from 1-5 nM in receptor binding assays using MC3R-expressing cell systems. The peptide functions as a full agonist at MC3R, producing robust cAMP responses with EC₅₀ values between 0.5-2.0 nM. MC3R-mediated signaling pathways involve Gs protein coupling and downstream activation of protein kinase A-dependent phosphorylation cascades.

MC4R Receptor Interactions

MC4R demonstrates high-affinity binding for Melanotan 2 with Kd values comparable to MC1R, typically 0.2-0.8 nM in membrane binding preparations. Functional assays measuring cAMP accumulation reveal potent agonist activity with EC₅₀ values ranging from 0.1-0.5 nM. MC4R signaling involves Gs protein activation and downstream modulation of neuronal firing patterns in hypothalamic cell culture systems.

Receptor Selectivity and Cross-Reactivity

Comparative Binding Affinity Analysis

Radioligand binding studies across melanocortin receptor subtypes demonstrate the following rank order of affinity for Melanotan 2: MC1R ≥ MC4R > MC3R > MC5R > MC2R. The peptide shows minimal binding to MC2R (adrenocorticotropin receptor) with IC₅₀ values exceeding 1000 nM in most assay systems.

Functional Selectivity Profiles

While Melanotan 2 binds with high affinity to multiple melanocortin receptors, functional responses vary across receptor subtypes. cAMP production assays reveal differential intrinsic activity, with MC1R and MC4R showing the highest efficacy values (>90% maximal response), while MC3R typically demonstrates 70-80% maximal efficacy relative to reference agonists.

Enzyme Kinetics and Metabolic Stability

Proteolytic Resistance

The cyclic structure of Melanotan 2 confers enhanced stability against proteolytic degradation compared to linear peptide analogues. In vitro stability assays using plasma enzymes and peptidases demonstrate half-lives exceeding 4-6 hours under physiological conditions, representing significant improvement over endogenous alpha-MSH (t₁/₂ ~2-3 minutes).

Receptor Internalization Kinetics

Following agonist binding, melanocortin receptors undergo β-arrestin-mediated internalization processes. Time-course studies in receptor-expressing cell lines demonstrate rapid internalization of MC1R and MC4R following Melanotan 2 treatment, with maximal internalization occurring within 30-60 minutes of peptide exposure.

Research Summary

Melanotan 2 represents a valuable research tool for investigating melanocortin receptor pharmacology across multiple receptor subtypes. Its high binding affinity, potent agonist activity, and enhanced metabolic stability make it particularly suitable for in vitro receptor studies examining MC1R-mediated melanogenesis pathways, MC3R signaling mechanisms, and MC4R-dependent cellular responses. The peptide's selectivity profile and functional characteristics provide researchers with a reliable pharmacological probe for dissecting melanocortin receptor biology in various cell culture systems and membrane preparations.

All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.